Controversy is brewing at the US Food and Drug Administration as reports emerge that Dr. Marty Makary, the agency's current commissioner, is planning to step down from his position. Makary, a renowned surgeon and medical researcher, has been at the helm of the FDA since January 2023, overseeing a tumultuous period in the agency's history. His departure comes as the FDA faces intense scrutiny over its handling of various high-profile issues, including the approval of certain medications and the regulation of emerging technologies in the healthcare sector. As speculation mounts about who will succeed Makary, industry insiders are bracing for a significant shift in the FDA's leadership and potential policy changes that may follow.
Marty Makary plans to resign from his post as FDA commissioner
